Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma
Jason Adhikaree(University of Nottingham), Poulam M. Patel(Nottingham University Hospitals NHS Trust)
Cited by 65
Related Papers
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
|Annals of Oncology|2019|282
Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)
|European Journal of Cancer|2011|210
Tumour‐mediated disruption of dendritic cell function: Inhibiting the MEK1/2‐p44/42 axis restores IL‐12 production and Th1‐generation
|International Journal of Cancer|2008|38